Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.840
-0.150 (-3.76%)
At close: Nov 16, 2026, 4:00 PM EST
3.925
+0.085 (2.20%)
After-hours: Nov 16, 2026, 7:59 PM EST

Nuvation Bio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
153.77164.0935.7242.65101.1132.42
Short-Term Investments
509.6365.13466.97568.56559.92632.97
Cash & Short-Term Investments
663.37529.21502.69611.21661.01765.39
Cash Growth
20.82%5.27%-17.76%-7.53%-13.64%254.76%
Accounts Receivable
36.5516.0812.72---
Other Receivables
3.683.293.573.72.493.04
Receivables
40.2219.3616.293.72.493.04
Inventory
15.3411.41----
Prepaid Expenses
15.7311.547.271.523.823.64
Total Current Assets
734.66571.52526.26616.43667.32772.07
Property, Plant & Equipment
16.414.482.994.324.693.66
Other Intangible Assets
19.811.214.62---
Other Long-Term Assets
7.527.616.760.730.140.42
Total Assets
778.39594.82540.63621.48672.14776.15

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.459.486.352.212.143.93
Accrued Expenses
57.1444.932.159.659.711.74
Short-Term Debt
5.975.726.28---
Current Portion of Long-Term Debt
16.519.59----
Current Portion of Leases
0.441.881.661.971.210.86
Current Income Taxes Payable
-0.290.680.140.110.4
Current Unearned Revenue
9.067.5211.12---
Other Current Liabilities
-2.87----
Total Current Liabilities
98.5682.2358.2413.9713.1616.93
Long-Term Debt
430.9847.21----
Long-Term Leases
14.232.540.972.043.052.19
Long-Term Unearned Revenue
6.6511.3115.57---
Other Long-Term Liabilities
-145.822.050.350.8511.04
Total Liabilities
550.42289.1176.8416.3617.0730.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,4471,4211,374947.75927.6909.99
Retained Earnings
-1,215-1,115-910.74-342.8-267-162.8
Comprehensive Income & Other
-4.62-0.190.570.18-5.53-1.19
Total Common Equity
227.98305.72463.79605.12655.08746
Shareholders' Equity
227.98305.72463.79605.12655.08746
Total Liabilities & Equity
778.39594.82540.63621.48672.14776.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
468.1366.948.924.014.263.06
Net Cash (Debt)
195.25462.27493.78607.21656.75762.34
Net Cash Growth
-42.73%-6.38%-18.68%-7.54%-13.85%253.34%
Net Cash Per Share
0.561.351.842.773.033.85
Filing Date Shares Outstanding
353.02347.6338.68219.05218.8219.06
Total Common Shares Outstanding
352.92346.5337.84219.05218.63217.95
Working Capital
636.1489.29468.01602.46654.16755.15
Book Value Per Share
0.650.881.372.763.003.42
Tangible Book Value
208.18294.5459.17605.12655.08746
Tangible Book Value Per Share
0.590.851.362.763.003.42
Machinery
-1.181.111.041.040.83
Construction In Progress
-0.03----
Leasehold Improvements
-0.540.350.340.320.24
SEC Filings: 10-K · 10-Q